Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47,770 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models.
Zhao X, Ren Y, Lawlor M, Shah BD, Park PMC, Lwin T, Wang X, Liu K, Wang M, Gao J, Li T, Xu M, Silva AS, Lee K, Zhang T, Koomen JM, Jiang H, Sudalagunta PR, Meads MB, Cheng F, Bi C, Fu K, Fan H, Dalton WS, Moscinski LC, Shain KH, Sotomayor EM, Wang GG, Gray NS, Cleveland JL, Qi J, Tao J. Zhao X, et al. Cancer Cell. 2019 May 13;35(5):752-766.e9. doi: 10.1016/j.ccell.2019.04.005. Cancer Cell. 2019. PMID: 31085176 Free PMC article.
Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas.
Zhang X, Zhao X, Fiskus W, Lin J, Lwin T, Rao R, Zhang Y, Chan JC, Fu K, Marquez VE, Chen-Kiang S, Moscinski LC, Seto E, Dalton WS, Wright KL, Sotomayor E, Bhalla K, Tao J. Zhang X, et al. Among authors: zhao x. Cancer Cell. 2012 Oct 16;22(4):506-523. doi: 10.1016/j.ccr.2012.09.003. Cancer Cell. 2012. PMID: 23079660 Free PMC article. Retracted.
Epigenetics, c-Myc and aggressive B-cell lymphomas.
Zhang Y, Zhao X, Tao J. Zhang Y, et al. Among authors: zhao x. Oncotarget. 2012 Nov;3(11):1264-5. doi: 10.18632/oncotarget.748. Oncotarget. 2012. PMID: 23175515 Free PMC article. No abstract available.
MYC and MiR: vicious circle.
Zhao X, Zhang X, Tao J. Zhao X, et al. Oncotarget. 2013 Dec;4(12):2168-9. doi: 10.18632/oncotarget.1602. Oncotarget. 2013. PMID: 24318653 Free PMC article. No abstract available.
Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma.
Zhao X, Lwin T, Silva A, Shah B, Tao J, Fang B, Zhang L, Fu K, Bi C, Li J, Jiang H, Meads MB, Jacobson T, Silva M, Distler A, Darville L, Zhang L, Han Y, Rebatchouk D, Di Liberto M, Moscinski LC, Koomen JM, Dalton WS, Shain KH, Wang M, Sotomayor E, Tao J. Zhao X, et al. Nat Commun. 2017 Apr 18;8:14920. doi: 10.1038/ncomms14920. Nat Commun. 2017. PMID: 28416797 Free PMC article.
BRD4: epigenetic origin and target of CTCL.
Zhao X, Tao J. Zhao X, et al. Blood. 2018 Feb 15;131(7):712-713. doi: 10.1182/blood-2017-12-820266. Blood. 2018. PMID: 29449301 Free article. No abstract available.
47,770 results
You have reached the last available page of results. Please see the User Guide for more information.